Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Theranostics
|
February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma
Filippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2023
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes
Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
January 9, 2026
Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study
Maria Kiriukova, Giulia Orsi, Vasile Sandru, et al.
Cancers
|
July 24, 2019
<i>ANGPT2</i> and <i>NOS3</i> Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
Giorgia Marisi, Elisabetta Petracci, Francesco Raimondi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 24, 2022
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples
Miriam Redegalli, Greta Grassini, Gilda Magliacane, et al.
Scientific Reports
|
February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer
Carlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
Gastrointestinal Tumors
|
November 27, 2019
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience
Giulia Rovesti, Giulia Orsi, Andrikou Kalliopi, et al.
Nutrients
|
January 11, 2025
Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT
Carolina Torres, Georgina Mancinelli, Jee-Wei Emily Chen, et al.
Gastrointestinal Tumors
|
November 27, 2019
Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort
Andrea Casadei-Gardini, Leonardo Solaini, Laura Riggi, et al.
Tumori
|
November 27, 2020
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus
Andrea Pretta, Pina Ziranu, Marco Puzzoni, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Theranostics
|
February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma
Filippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2023
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes
Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
January 9, 2026
Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study
Maria Kiriukova, Giulia Orsi, Vasile Sandru, et al.
Cancers
|
July 24, 2019
<i>ANGPT2</i> and <i>NOS3</i> Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
Giorgia Marisi, Elisabetta Petracci, Francesco Raimondi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 24, 2022
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples
Miriam Redegalli, Greta Grassini, Gilda Magliacane, et al.
Scientific Reports
|
February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer
Carlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
Gastrointestinal Tumors
|
November 27, 2019
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience
Giulia Rovesti, Giulia Orsi, Andrikou Kalliopi, et al.
Nutrients
|
January 11, 2025
Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT
Carolina Torres, Georgina Mancinelli, Jee-Wei Emily Chen, et al.
Gastrointestinal Tumors
|
November 27, 2019
Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort
Andrea Casadei-Gardini, Leonardo Solaini, Laura Riggi, et al.
Tumori
|
November 27, 2020
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus
Andrea Pretta, Pina Ziranu, Marco Puzzoni, et al.
Page
of 6